Overall survival for epithelial ovarian cancer (EOC) patients is prolonged approximately 5 months as a result of treatment with beta blockers, a type …
Sourced through Scoop.it from: thespeaker.co
September 16, 2015 by 2012pharmaceutical
Overall survival for epithelial ovarian cancer (EOC) patients is prolonged approximately 5 months as a result of treatment with beta blockers, a type …
Sourced through Scoop.it from: thespeaker.co
I was wondering whether there are more reliable evidences about the cancer survival.
I think that this amazing, and medical oncologists must know about this new utility of old drugs(cheaper that MABs).Sometimes the clinitian prescribes this drug in another setting in these patiens(cardiovascular) and benefit the cancer patient……………..
I will later in the week provide a curation of the history of the rationale for this study. It starts with microarray experiments done in the late 90’s.